Axsome Therapeutics (AXSM) Shares Outstanding (2015 - 2026)

Axsome Therapeutics has reported Shares Outstanding (Entity) for 12 years, with the latest figure at $51.4 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 4.48% year-over-year to $51.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.4 million (up 4.48% YoY) and the FY2025 annual result came in at $50.9 million, up 4.55% from the prior year.
• Shares Outstanding (Entity) climbed to $51.4 million in Q1 2026 per AXSM's latest filing, from $50.9 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $51.4 million in Q1 2026 and troughed at $38.9 million in Q1 2022.
• A 5-year average of $46.7 million and a median of $47.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) climbed 17.07% in 2023, then advanced 2.3% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $43.5 million in 2022, then grew by 8.86% to $47.4 million in 2023, then advanced by 2.78% to $48.7 million in 2024, then advanced by 4.55% to $50.9 million in 2025, then rose by 1.06% to $51.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $51.4 million, $50.9 million, and $50.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.